The document discusses how to effectively summarize and present biological data in slides. It recommends decomposing raw data into sections, looking inside each section to identify the core message, and visualizing the messages in slides. Example slides are presented that visualize prevalence of low back pain by region. Key messages are extracted and presented concisely with visualization.

1. BIO
LOGYASPECT
KNOWING
HOW TO
DEAL WITH
SLIDES
CLEAR &
ATTRACTIVEFROM THE

2. IF WE
WANT TO
KNOW MORE
ABOUT
LEAF
A
WHILE WE
HAVE SOME
CONTENTS
TO SHARE

3. WE MIGHT
PUT IT
UNDER A
MICRO
SCOPE
THE CONTENTS
SHOULD BE
EXTRACTED

4. IT TO
SEVERAL
PARTS
DIVIDE
DECOMPOSE
YOUR CONTENTS
TO SECTIONS

5. FOCUS ON
A PART OF IT
& GET
CLOSER
LOOK INSIDE
EACH SECTION

6. UNTIL YOU FIND THE
CORE
DEFINE A
CORE MESSAGE
FOR EACH
SECTION &
ARRANGE
A MESSAGE
IN A SLIDE

7. THE
MARVELLOUS
DISCOVERY
WE GET
ENJOY
VISUALISE
THE MESSAGE
WITH THE
SLIDE CHEMISTRY
WAY WE’VE
TALKED

8. RAW
DATA
BIOLOGICAL
DECOMPOSE
IT
LOOK
INSIDE
A MESSAGE
A SLIDE
VISUALISE
IT
T R A N S F O R M A T I O N

9. WAY TO OUR CONTENTS
BIO
LOGY
TRY

10. The global age-standardised point prevalence of LBP (from 0 to 100 years of age) in 2010
was estimated to be 9.4% (95% CI 9.0 to 9.8). It was higher in men (mean: 10.1%; 95% CI
9.4 to 10.7) compared with women (mean: 8.7%; 95% CI 8.2 to 9.3). The age and sex
distribution across regions was similar. DisMod-MR assumes a similar age pattern for all
regions unless there are sufficient data points in a region to indicate a variation from the global
age pattern. The large heterogeneity in the LBP dataset meant that there was no departure
from the default of a common age pattern. Prevalence peaked at around 80 years of age.
Age-standardised prevalence in 2010 was highest in western Europe (mean: 15.0%; 95% CI
14.1 to 16.0) followed by North Africa/Middle East (mean: 14.8%; 95% CI 13.8 to 15.9), and
lowest in the Caribbean (mean: 6.5%; 95% CI 5.6 to 7.4) followed by central Latin America
(mean: 6.6%; 95% CI 5.8 to 7.4).
LBP Prevalence
Dr Damian Hoy, University of Queensland, School of Population Health,
Herston Rd, Herston, QLD 4006, Australia
RAW DATA

11. The global age-standardised point prevalence of LBP (from 0 to 100 years of age) in 2010
was estimated to be 9.4% (95% CI 9.0 to 9.8). It was higher in men (mean: 10.1%; 95% CI
9.4 to 10.7) compared with women (mean: 8.7%; 95% CI 8.2 to 9.3).
The age and sex distribution across regions was similar. DisMod-MR assumes a similar age
pattern for all regions unless there are sufficient data points in a region to indicate a variation
from the global age pattern. The large heterogeneity in the LBP dataset meant that there was
no departure from the default of a common age pattern. Prevalence peaked at around 80
years of age.
Age-standardised prevalence in 2010 was highest in western Europe (mean: 15.0%; 95% CI
14.1 to 16.0) followed by North Africa/Middle East (mean: 14.8%; 95% CI 13.8 to 15.9),
and lowest in the Caribbean (mean: 6.5%; 95% CI 5.6 to 7.4) followed by central Latin
America (mean: 6.6%; 95% CI 5.8 to 7.4).
DECOMPOSE
YOUR CONTENTS
INTO SECTIONS

12. The global age-standardised point prevalence of LBP (from 0 to 100 years of age) in 2010
was estimated to be 9.4% (95% CI 9.0 to 9.8). It was higher in men (mean: 10.1%; 95%
CI 9.4 to 10.7) compared with women (mean: 8.7%; 95% CI 8.2 to 9.3).
The age and sex distribution across regions was similar. DisMod-MR assumes a similar age
pattern for all regions unless there are sufficient data points in a region to indicate a variation
from the global age pattern. The large heterogeneity in the LBP dataset meant that there was
no departure from the default of a common age pattern. Prevalence peaked at around 80
years of age.
Age-standardised prevalence in 2010 was highest in western Europe (mean: 15.0%;
95% CI 14.1 to 16.0) followed by North Africa/Middle East (mean: 14.8%; 95% CI 13.8
to 15.9),
and lowest in the Caribbean (mean: 6.5%; 95% CI 5.6 to 7.4) followed by central Latin
America (mean: 6.6%; 95% CI 5.8 to 7.4).
LOOK INSIDE
EACH SECTION
TO DIG OUT THE
CORE MESSAGE

13. HIGH:
Western Europe is 15.0%
North Africa/Middle East is 14.8% A MESSAGE
A SLIDE
The global point prevalence of LBP (from 0 to 100 years of
age) in 2010 is 9.4%
men is 10.1%, women is 8.7%
LOW:
Caribbean is6.5%
Central Latin America is 6.6%
1
2
3

14. in 2010
(from 0 to 100
years of age)
9.4
10.1
8.7
Dr Damian Hoy, University of Queensland, School of Population Health,
Herston Rd, Herston, QLD 4006, Australia
PREVALENCE
OF LBP
GLOBAL
VISUALISE IT

15. 151ST
14.8
2ND
PREVALENCE
OF LBP
HIGH
DISTRIBUTION
VISUALISE IT
Dr Damian Hoy, University of Queensland, School of Population Health,
Herston Rd, Herston, QLD 4006, Australia

16. VISUALISE IT
Dr Damian Hoy, University of Queensland, School of Population Health,
Herston Rd, Herston, QLD 4006, Australia
6.5
6.6
1ST
2ND
PREVALENCE
OF LBP
LOW
DISTRIBUTION

17. BIO
LOGY
PRO
CESS
FOLLOW THE
TO DO SLIDES
D
L
A
V

18. 美學行銷
Aesthetic Marketing
Presentation / Infographics
Coach / Analysis / Design
Perpa Hsieh
perpahsieh@gmail.com
AESTHETIC
MARKETING,
perpahsieh.wix.com/amblog